跳至主要内容
临床试验/CTRI/2024/08/072002
CTRI/2024/08/072002尚未招募Unknown

A comparative study to evaluate the efficacy and safety of Diltiazem hydrochloride 2 percent w/w plus Lidocaine hydrochloride 2 percent w/w Gel with Lignocaine Hydrochloride Gel 2 percent w/w in anal fissure patients A Prospective Randomized Open-Label Single Centre Comparative Study - NI

Abbott India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Males and females with age 18 to 64 years (both inclusive) with a diagnosis of anal fissure
  • Willing to stop all other concomitant topical preparations applied peri-anally prior to commencing study treatment and throughout the study
  • Subjects who understand the requirement of the study and is willing to sign and date written informed consent to participate in the study

排除标准

  • Subjects unwilling to have an examination of anal fissure
  • Subjects having anal fistulas or anal fissure of various causes such as Crohn disease anal suppuration abscesses
  • Subjects who have or have undergone the following gastrointestinal disorders or procedures Inflammatory bowel disease chronic fecal
  • incontinence anal abscess a history of radiation therapy to the pelvis fixed anal stenosis/fibrosis
  • Subjects with a history of neoplastic disease within 5 years
  • Subjects with associated acute hemorrhoidal attacks
  • Subjects having anal or perianal cancer
  • Subjects who have had lateral sphincterotomy or anal stretch or other previous surgery involving the anal canal or perianal region
  • Subjects with a clinically significant history of renal hepatic neurological dermatological immunological major psychiatric (including drug or alcohol abusers) or hematological illness
  • Subjects of hypertension / ischemic heart disease on oral calcium channel blockers
  • Subjects with atrial fibrillation associated with other conditions
  • Subjects with cardiovascular disease
  • Subjects who have previously received therapy with diltiazem hydrochloride cream nitrates vasodilator or other topical calcium channel blockers
  • Subjects with hypersensitivity to any of the ingredients in the study drug
  • Females of childbearing potential must have a negative pregnancy test and be non-lactating
  • Subjects who are unsuitable for any other reason to participate in the study in the opinion of the investigator

研究者

相似试验